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hydrated choline ionic liquids on lactate oxidase
biofunctionality in sensor applications
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Vijayaraghavan Ranganathan,c Douglas R. MacFarlane,c Fernando Benito-Lopez*ad
and Dermot Diamonda
This paper presents an extended study on the ion eﬀects of a series of biocompatible hydrated choline
based ionic liquids (ILs) on lactate oxidase (LOx), an important enzyme in biosensing technology for the
in vitro detection of lactic acid. Secondary structural analysis revealed changes in the protein conformation
in hydrated ILs, while thermal unfolding/aggregation dynamics showed diﬀerent profiles in the presence or
absence of ILs. Moreover, LOx thermally denaturised at 90 1C showed residual activity in the presence of
chloride and dihydrogen phosphate anions. Kinetic and lifetime studies were also performed, providing a
better understanding of the ion eﬀects of ILs on the biocatalytic activity of the enzyme.
Introduction
Preserving the native state of proteins plays a vital role in
maintaining their biofunctionality and activity. Retaining protein
functionality over time is a key factor in the pharmaceutical field,
as it determines the stability of protein-based drugs.1 In this
regard, a shelf life between 18–24 months is required for economic
practicability. At the same time, with the exponential growth
of point-of-care technologies, there is an increasing demand
for physically and chemically stable enzyme formulations for
biosensing, as this determines device lifetime.2
In general, irreversible changes to the folded state enzyme
conformation can be induced by factors such as temperature,
pH and specific ion interactions.3 Approaches to improve the
enzyme stability can be classified into two main categories:
(1) the modification of the enzyme state and (2) the optimisation
of the solvent environment.4 Themodification of the enzyme state
can be achieved in several ways: by isolation of structural variants
extracted from natural organisms capable of existing in extreme
environments, by rationale-based mutagenesis (bioengineering),
by directed evolution of the enzyme or by PEGylation.5,6
The optimisation of the solvent environment, on the other
hand, involves the use of surfactants and additives, changes
in pH and/or the ionic strength of aqueous media.3 Parallel to
this, the use of organic (non-aqueous) media in enzymology has
been explored in recent years since this can improve enzyme
performance in certain cases.7 Ionic liquids (ILs) have recently
emerged as a new class of organic solvents that may have
considerable potential for enzyme stabilisation.8
ILs are molten salts having melting points below that of
water. They have made considerable impact in several research
areas, such as catalysis,9 electrochemistry,10 biosensing11 and
biochemistry.12 The properties of ILs depend dramatically on
the cation–anion combination and in this sense, properties
such as polarity, viscosity, thermal stability and conductivity can
be tailored via the appropriate cation–anion combination.13 This
is an attractive proposition, since it is possible to design a
solvent that has the optimum characteristics to improve, for
example, the limited temperature and pH range in which many
enzymes are stable when solubilised in water.8
A common strategy to improve the stability of proteins is to use
a controlled amount of water in the IL (between 20–30% w/w), to
produce so-called hydrated ILs (HyILs), which provide the required
hydrogen-bonding environment for protein solubilisation.8 For
example, extended stability of cytochrome C was observed in
hydrated choline dihydrogen phosphate (HyCDHP).14 Several other
studies have reported similar beneficial effects for mushroom
tyrosinase,15 ribonuclease A,16 interleukin-217 and even DNA in
hydrated choline ILs.18 Moreover, ILs based on the choline
cation are now commonly used in many applications for which
biocompatibility is an essential requirement, i.e. cell cultures or
in vivo applications.19,20
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The use of ILs in bioelectrochemistry has been summarised
in a recent review by Fujita et al.,21 showing how ILs are now
widespread in many electrochemical applications, e.g. as bio-
fuel cell electrolytes for which more stable matrices are needed.
Another growing field for ILs is biosensing, where they are used
for the modification of electrodes, acting as a binder for carbon
matrix (‘‘Bucky gel’’) electrodes or for the immobilisation of
bioreceptors.22 We recently demonstrated the application of ILs
as an electrolyte for the development of organic electrochemical
transistors (OECTs), for sensing glucose11 and lactic acid (LA).23
For the latter, the IL was incorporated into a polymeric matrix
(an ionogel) to achieve a solid-state electrolyte.
Lactic acid is an important metabolic analyte involved in
many physiological processes24 and in sports performance.25
Consequently, there is considerable interest in lactate biosensors,
but despite substantial body of research, the relatively poor
stability of L-lactate oxidase (LOx) limits the eﬀectiveness of
current devices.26,27 LOx is a flavin mononucleotide (FMN)
enzyme that catalyzes the oxidation of L-lactic acid into pyruvate,
producing H2O2 in the process. LOx from the Aerococcus viridans
contains two tightly packed tetramers, in which each enzyme
monomer holds a non-covalently bound FMN group.28
Herein, we investigate the use of hydrated choline cation-
based ionic liquids in the stabilisation of lactate oxidase. In
particular, this work focuses on the eﬀects of diﬀerent HyILs on
the biofunctionality of LOx, with particular emphasis on the
influence of the HyILs on the enzyme secondary structure, and
on the biocatalytic activity. The outcome of long-term stability
studies of LOx in several HyILs and PBS is also reported.
Materials and methods
Chemicals
Lactate oxidase from Aerococcus viridans Grade I (EC 1.13.12.4)
for sensor technology was kindly provided by Roche Diagnostics
Deutschland GmbH as a lyophilised yellow powder. Choline
formate (CF), choline levulinate (CL), choline nitrate (CN), choline
tartrate (CT), choline valproate (CV), choline aminoacetate (CAAc)
and choline gallate (CG) were synthesised by neutralisation
reaction of the selected acidic form of the anion with choline
hydroxide, following the procedure described elsewhere.19,29
Choline dihydrogen phosphate ionic liquid buﬀer (CDHP/B)
was synthesised as described elsewhere.30 It typically involves
the addition of 6.30 g (0.5 mol) of choline hydroxide (20 wt% in
water) in a beaker containing 4.02 g of dry CDHP (1 mol), with
stirring at room temperature until it becomes a clear solution.
The water content (calculated) in this buﬀer mixture at this stage
is 48% and the remaining 52% is ionic liquid. Choline dihydrogen
phosphate (CDHP) was purchased from IOLITEC (Denzlingen,
Germany). Choline chloride (CCl) was purchased from Sigma-
Aldrichs (San Diego, USA). CF, CL and CG are liquids at room
temperature while the other ILs are solids under ambient
conditions. Horseradish peroxidase (HRP), 4-aminoantipyrine
(4APP), hydroxybenzoic acid (HBA), lactic acid, pH phosphate
tablets pH 7.4, and monobasic and dibasic potassium
phosphate were obtained from Sigma-Aldrichs (San Diego,
USA) and used as received.
Preparation of LOx solutions
HyIL solutions for circular dichroism spectroscopy (CD), long-
term and residual activity studies were prepared with final
water content of 25% w/w, except for CT where a 35% w/w
solution was employed. Generally, HyIL–LOx solutions were
prepared starting from 20% w/w (30% w/w for CT) water
content in HyILs, where the right amount of water with LOx
was added in order to reach the desired final water weight
percentage and protein concentration. Notice that for CCl and CG
it was not possible to obtain similar experimental hydrated condi-
tions (25% or 35% w/w). LOx solutions in the presence of CCl and
CG were prepared by dissolving CCl and CG in PBS (pH 7.4;
10 mM) at a final concentration of 1 M. In this case the use of
PBS for the CCl and CG solutions was necessary in order to control
the pH of the solutions, providing a straightforward comparison of
these results with the IL-free solution. Hereafter they will be
referred to as CG and CCl solutions. Moreover, LOx–IL-free solution
(PBS 7.4; 10mM) was also studied for comparison. PBS is used as a
reference system in order to establish variations in the standard
behaviour of the LOx enzyme when compared to non-conventional
solvents, such as HyILs.
In order to ascertain the eﬀective solubilisation of LOx in the
HyIL solutions an UV-vis nanodrop system (Thermo Scientific –
NanoDrop 2000c) was employed, following a similar protocol to
the one described by Weaver et al.17 These experiments showed
a negligible UV absorbance signal in the region of the spectra in
which the ILs and the enzyme do not absorb, indicating that
LOx was completely solubilised (data not shown).
Circular dichroism spectroscopy
The secondary structure of the enzyme was investigated by circular
dichroism spectroscopy in the far-UV region (190–250 nm) using a
JASCO CD J-810 spectropolarimeter. CD spectra were recorded
using a 0.1 cm path length quartz cuvette loaded with 300 mL of
the sample at the final concentration of 0.25 mg ml1 of LOx.
Temperature induced denaturation of the protein was performed
from 25 1C to 90 1C at the scan rate of 1 1C min1 at 222 nm.
Quantitative secondary structure analysis of LOx in solution was
performed by fitting the far-UV CD data using the published
analysis algorithms CDSSTR (reference set 4) of the online server
DICHROWEB.31,32
Colorimetric assays
Colorimetric assays for residual activity, kinetic and long-term
stability studies were performed using a TECAN Infinite M200
96 well plate reader. All the experiments were run at 25 1C. A red
chromogenic dye (lmax = 510 nm) is formed from the following
cascade of reactions upon addition of lactic acid:
Lactic acidþO2 !LOx PyruvateþH2O2 (1)
2H2O2 þ 4AAPþHBA !HRP quinoneiminedyeþ 4H2O (2)
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The composition of the assay was: 0.2 mM of 4AAP, 6 mM of
HBA, 0.4 Unit per well (300 mL) of HRP and 50 nM of LOx in PBS
at pH 7.0 (0.15 M).
Long-term stability and residual activity. Long-term stability
and residual activity studies were performed by adding to the
final assay solution only 5 mL of the LOx solution (IL-free
solution, CCl, CG and HyILs). The dissolution of a small
amount of HyIL–LOx and the relatively high molarity of the
PBS of the colorimetric assay guarantee a minimal pH shift
from neutrality, which might be caused by the acid/base
character of some of the studied ILs. A lactic acid concentration
of 10 mM was used to start the cascade of reactions. The long-
term stability of the protein was investigated using LOx stock
solutions stored at 5 1C and 37 1C, which were periodically
tested over a period of 140 days. Residual activity tests upon
conditioning of the LOx solutions at 90 1C were similarly
performed. Denaturation was induced by incubation of the
samples in a thermostatic standard silicone oil bath.
Kinetic studies. To determine the kinetic parameters of LOx,
solutions at the concentration of 0.5 M in ILs were employed in
all the cases. This IL molarity guarantees the dominance of ion-
specific eﬀects on the enzyme rather than electrostatic forces.33
Moreover, compared to the long-term stability and residual
activity studies, a higher HRP concentration was employed
(4 units per well) in order to take into account the possible eﬀect
of the ILs on the HRP. Under these experimental conditions, the
production of hydrogen peroxide from LOx is assumed to be the
only limiting step for the cascade of reactions. Furthermore, due
to the higher IL concentrations, the pH of the PBS assay was
aﬀected and so its variation was recorded using a standard glass
membrane pH meter (VWR, sympHony SP70P). Kinetic constants
(KM and Vmax) were obtained from the data through a nonlinear
fitting of the Michaelis–Menten equation using an in-house Excel
developed macro.† Turnover numbers (kcat) were calculated from
Vmax using the relationship, kcat = Vmax/[E] where [E] is the molar
enzyme concentration, i.e. 50 nM.
Results and discussion
Eﬀect of the ionic liquids on LOx structure and conformation
Fig. 1(a) presents the CD spectra at 25 1C (solid line) for lactate
oxidase when in IL-free aqueous solution. The spectrum clearly
shows the three characteristic peaks at 195 nm, 208 nm and
222 nm originating from the folded secondary structure of the
enzyme. However, for CCl, the CD spectrum presents only two
of these characteristic peaks at 208 nm and B220 nm, as
shown in Fig. 1(b) (solid line). The high absorbance, due to
CCl in solution in the region 200–190 nm, made any quantita-
tive analysis difficult. In the case of the different HyIL–LOx
solutions and CG, high absorbance in most of the far-UV region
was observed, making any CD spectral recording impractical.
Blank experiments using enzyme-free HyILs revealed that the
HyILs are responsible for the high absorbance (data not shown).
Nevertheless, in the case of LOx dissolved in HyCDHP it was
possible to record the full spectrum over the entire far-UV region
(Fig. 1(c) – solid line), from which useful information about the
secondary structure of LOx in HyCDHP can be extracted.‡
Comparing the three spectra in Fig. 1, some diﬀerences in
the secondary structure of LOx at 25 1C (1) are observed,
especially for HyCDHP where a less pronounced peak at
208 nm is visible, which implies that changes are occurring
in the secondary structure of LOx. This is verified by the
quantitative analysis (Table 1), which shows substantial diﬀerences
in the a-helix and b-sheet content for HyCDHP compared to IL-free
solution. For instance, LOx in HyCDHP presents only 11% of
a-helices, compared to 28% in IL-free solution. Conversely, a higher
content of b-sheets and turns are observed for LOx when dissolved
in HyCDHP. In this case, they represent 34% and 24% of the
secondary structure, respectively, suggesting that a change in the
conformation of the enzyme in HyCDHP arises due to the diﬀerent
ionic environment.
Fig. 1 CD spectra of LOx dissolved in IL-free solution (a), CCl (b) and
HyCDHP (c). The spectra were first recorded at 25 1C (1) (—), then thermal
denaturation of the LOx was performed at 1 1Cmin1 till 90 1C, followed by
the recording of spectrum at 90 1C (  ). Once the sample was cooled
down the spectrum at 25 1C (2) (---) was recorded. The LOx concentration
is 0.25 mg mL1 in all the cases.
† Non-linear fitting was performed through minimisation of the sum of the
square residuals (SSR) using the Solver function.
‡ The less intense CD signal for HyCDHP/LOx is possibly due to the higher
refractive index of HyCDHP (RIHyCDHP = 1.49) compared to CCl and IL-free
solution.
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It is known that a stabilising solvent often will produce an
increase in the melting point of proteins, which implies that
unfolding is less favorable at room temperature.16,17 Fig. 1(a) and
(c) show the CD spectra recorded at 90 1C (no useful data at this
temperature were obtained for CCl) compared with equivalent
spectra obtained at 25 1C after denaturation, Fig. 1 (dashed lines).
At 90 1C, both spectra present less intensive peak signals at
around 200 nm, and a substantial wavelength shift for the three
peak maxima. Moreover, the peak at B195 nm in the IL-free
spectrum (predominantly given by the a-helices) has significantly
reduced at 90 1C. On the other hand, the same peak in the
HyCDHP spectrum (Fig. 1c) is still substantially present at 90 1C,
implying that recovery of the original structure occurs once the
sample is cooled down to 25 1C.
This conclusion is supported by the data in Table 1, where
the decrease in the a-helix content of LOx in HyCDHP is only
ca. 3%, much smaller than the 10% decrease observed in the
IL-free sample. In addition, for IL-free samples, the concomitant
increment in b-sheets, turns and unordered content that occurs
upon thermal denaturation suggests that irreversible aggrega-
tion of the enzyme is happening. In fact, high levels of inter-
molecular b-sheet structures typically indicate aggregation.3
The formation of aggregates in the IL-free case is verified by the
change in the photomultiplier voltage value (High Tension – HT) of
the spectropolarimeter during the thermal denaturation of LOx,
Fig. 2(a) (solid line). In fact, Benjwal et al.34 proposed an easy
method to monitor real-time aggregation of proteins, by following
changes in light scattering, as this correlates with variations in the
particle size (aggregates). Alternatively, monitoring the CD-signal at
222 nm can provide information about the unfolding of proteins.
Fig. 2(a) shows a sharp transition of the signal (solid black line)
starting at 68 1C, with a similar effect occurring at 222 nm (solid
light grey line), suggesting that unfolding and aggregation of LOx
proceed simultaneously. For CCl, a sharp variation of the MRE
(Mean Residual Ellipticity) signal at 222 nm suggests unfolding of
LOx but the HT value versus temperature does not clearly support
aggregation, although it does increase. This behavior can be
attributed to aggregation of the unfolded enzyme being less
favoured aggregation of the unfolded enzyme due to the presence
of CCl. In contrast, both the HT and MRE curves for the HyCDHP/
LOx do not present any similar transitions.
The decrease of the MRE signal may suggest that some
unfolding of LOx is happening, as is also indicated in Table 1
from the quantitative analysis of the CD spectra for HyCDHP.
With regard to the HT value for HyCDHP (Fig. 2(c)), a less well-
defined step increase is observed starting at ca. 72 1C, which
implies that aggregation of the enzyme is inhibited compared
to IL-free and CCl LOx solutions, due to the ionic eﬀect and the
greater viscosity of HyCDHP.
The structural analysis does not provide any information on
the capability of the enzyme to retain its catalytic activity after
thermal denaturation. Therefore, the residual activity was
characterised by incubating the LOx solutions at a constant
temperature of 90 1C for diﬀerent times, as explained in the
experimental section. Choline valproate, choline aminoacetate
and choline gallate were found to be strong denaturating
agents for the enzyme. In fact when LOx was dissolved in those
HyILs and then tested, no catalytic activity was observed. For
this reason CV, CAAc and CG were not studied any further.
In contrast, LOx exhibited catalytic activity when dissolved
in HyILs, i.e. HyCF, HyCL, HyCN and HyCT. However, upon
incubation of these HyIL–LOx solutions at 90 1C, their residual
activity was negligible after 5 min. A similar behaviour was also
observed for the IL-free–LOx solution. These results indicate
that thermal induced denaturation of LOx in those solutions is
irreversible, leading to the entire loss of biocatalytic activity.
This behaviour is expected for the LOx–IL-free solution, considering
the aggregation dynamics shown in Fig. 2(a). Unfortunately, the
lack of CD data obtained for the LOx solutions in HyCF, HyCL,
HyCN and HyCT do not allow us to predict whether unfolding
is occurring, with loss of bioactivity, regardless of enzyme
aggregation.
For CCl and HyCDHP the thermal deactivation profiles are
quite diﬀerent. Fig. 3 displays the residual activity of LOx versus
incubation time, showing how most of the activity loss occurs
during the first 5 minutes of incubation (B75%), followed by a
progressive decrease, which becomes completely irreversible
between 25 and 30 min. These results correlate well with
the previous observations on the conformational changes of
LOx when dissolved in CCl and HyCDHP. Although enzyme
Table 1 Secondary structure analysis of LOx in IL-free solution and
HyCDHP, with reported values in percentage. Quantitative CD analysis
was performed for spectra recorded at 25 1C before (1) and after (2)
thermal denaturation at 1 1C min1 till 90 1C of the LOx. NRMSD states for
normalised root mean square deviation
25 1C (1) 25 1C (2)
IL-free HyCDHP IL-free HyCDHP
a-Helices 28 11 18 8
b-Sheets 23 34 30 37
Turns 20 24 28 25
Unordered 30 30 23 30
NRMSD 0.011 0.087 0.039 0.116
Fig. 2 Thermal denaturation of LOx dissolved in IL-free solution (a), CCl
(b) and HyCDHP (c). The (—) HT value and the (—) MRE (Mean Residual
Ellipticity) at l = 222 nm was recorded from 25 1C to 90 1C at 1 1C min1.
LOx concentration is 0.25 mg mL1 in all cases.
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unfolding occurs in all cases, it appears that this process is
quite reversible when denaturation conditions are applied for a
short period of time (5–30 min). This is a clear demonstration
that the presence of CDHP and CCl enhances the stability of
LOx when it is thermally stressed.
Eﬀect of the ionic liquids on the LOx biofunctionality
In order to obtain more information on the eﬀects of the
diﬀerent ILs on the lactate oxidase function, kinetic character-
isation of the enzyme aqueous solutions in the presence of ILs
(0.5 M) was carried out. Fig. 4 shows the experimental data
points fitted using the Michaelis–Menten non-linear model35
and Table 2 summarises the calculated kinetic parameters
KM and kcat and the catalytic efficiency given by the ratio kcat/KM.
Moreover, experimental pH measurements of the final assay
solutions in the absence and presence of lactic acid are also
reported in Table 2. It was found that addition of the IL causes
a change in the pH, in some cases producing an increase (e.g.
CF, pH 7.0 - 7.2) or a decrease (e.g. CDHP, pH 7.0 - 6.0)
depending on whether the anion behaves as a Brønsted acid
(DHP) or base (formate). Addition of lactic acid in the presence
of the ILs in all the cases reduces the pH, typically by ca. 0.1 pH
unit or less.
It should be noted that it was not possible to measure any
kinetic parameters for choline tartrate, probably because of the
significant degree of dissociation of the dicarboxylic anion,
which generates an environment which is too acidic (pH = 3.6)
for the enzyme to retain its functionality, as LOx has optimum
activity between 6.5 and 7.5; as suggested by the enzyme
supplier.
Table 2 presents the results obtained for KM and kcat values
in the various aqueous environment studies. KM represents the
aﬃnity of the enzyme for the substrate, and for a given reaction
velocity a low value of KM indicates a better aﬃnity between the
two, whereas kcat represents the turnover number of the enzyme
(the number of substrate molecules converted into product
by the enzyme). The catalytic eﬃciency (overall eﬀectiveness of
the biocatalytic behaviour of the enzyme) is given by the ratio
kcat/KM. Taking the catalytic eﬃciency first, it is clear that this is
significantly reduced (approximately 5 fold) for all ILs com-
pared to IL-free solution (100% water), except for CCl, which is
reduced by ca. 30%; i.e., the catalytic activity of CCl is about
3 times greater than the other ILs tested. This relates closely to
the kcat values, which are always lower for the ILs and CCl
compared to IL-free solution. The picture of variation in KM is
little more complex, as the values of IL-free solution and CCl
closely match (0.37 mM and 0.36 mM, respectively), for CN it is
slightly higher (0.47 mM), while for other ILs they are higher
again, in the range 0.8–0.9 mM. This result suggests that in the
presence of ILs, the enzyme and substrate interactions are
weakened and it is believed that such effect can be mainly
attributed to the anions of the tested ILs.
Considering the catalytic eﬃciency values as the key para-
meter, the following relationship can be expressed for the
influence of the anion on the biocatalytic activity of lactate
oxidase in choline-based ILs;
Cl > nitrate > Levulinate > DHP > Formate
Since the first observation by Hofmeister, the eﬀect of ions
on protein stability has been mostly attributed to their ability to
modify the water distribution around and within the protein
hydration environment.36 In order to understand the cause of
this eﬀect, the kosmotropic (‘structure-making’) and chaotropic
(‘structure-breaking’) nature of ions must be considered, as
these are important parameters in terms of stabilising or
destabilising specific ion eﬀects on proteins. Several studies
Fig. 3 Residual activity of LOx dissolved in HyCDHP (&) and CCl at 1 M in
PBS at pH 7.4 (K) upon thermal denaturation at 90 1C.
Fig. 4 Initial velocity of LOx versus lactic acid concentration (n = 3). CCl
and IL concentration in the final assay is equal to 0.5 M. Fitting curves result
from exponential Michaelis–Menten non-linear fitting.
Table 2 Kinetic parameters and pH values of LOx solutions in the absence
(IL-free) and presence of ILs (concentration 0.5 M)
KM [mM] kcat [s
1] kcat/KM [s
1 mM1] pH no LA
IL-free 0.370 78.80 210.81 7.0
CCla 0.356 50.66 142.30 6.9
CDHP 0.872 38.26 43.88 6.0
CF 0.926 37.47 40.46 7.2
CL 0.757 37.23 49.18 7.2
CN 0.465 23.10 49.68 6.8
a Kinetic parameters in the presence of choline chloride were deter-
mined under similar experimental conditions as those of other ILs,
with a final concentration equal to 0.5 M.
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have revealed that the best stabilising conditions are normally
provided by chaotropic cations and kosmotropic anions.36–39
Choline is well known as a chaotropic cation for the stabilisation of
proteins when coupled with a kosmotropic anion, such as DHP.37
According to the Hofmeister anion series, DHP is considered a
stabilising anion, while nitrate and chloride anions are normally
considered as strong and slightly destabilising anions, respec-
tively.36 No relevant data could be found for the levulinate anion,
while several reports suggest that formate ILs can produce positive
stabilisation effects,40,41 although this has not been specifically
related to either its stabilising or destabilising nature.
Maeda-Yorita et al.42 described an enhanced stabilisation
eﬀect on the bioactivity of LOx from chloride anions, which is
broadly in accordance with our findings. However, the results
for nitrate and DHP are not so easy to interpret. In fact, in the
established anion series, the relative position of DHP compared
with nitrate is not in line with previously reported studies.16,36
CDHP is known as a slightly acidic IL, due to the acidic
character of the DHP anion (H2PO4
).43 This is supported
by the pH values reported in Table 2, which show a decrease
of the solution pH in the presence of CDHP (pH 6.0 compared
to 7.0 for IL-free). The other IL solutions generate a less
pronounced pH shift (0.2 pH units) compared to IL-free
solution. Together with the specific ion eﬀects, the pH variation
of the solution when adding CDHP could possibly explain the
lower catalytic eﬃciency of lactate oxidase (LOx optimum pH
activity is between 6.5 and 7.5).
MacFarlane et al.30 reported the possibility of controlling
proton activity in HyILs, obtaining an intrinsic proton buﬀering
behavior of CDHP, denoted here as CDHP/B. Table 3 reports the
kinetic parameters when CDHP/B is used in solution instead of
CDHP and Fig. 5 shows the kinetic curves for CDHP/B, with
CDHP and IL-free solution for comparison. Firstly, the pH
increases substantially (B0.80 pH units) when CDHP/B was
added to the assay solution, reaching the optimum pH window
for LOx; this is due to the inherent equilibrium of the dihydro-
gen phosphate and mono-hydrogen phosphate groups in
CDHP/B. Secondly, KM decreases and kcat increases in compar-
ison to CDHP, which contributes to a substantial improvement
in the catalytic eﬃciency of LOx, increasing to 130.64 s1 mM1
(ca. 3 times greater than CDHP) but still less than IL-free–LOx
solution (210.81 s1 mM1). Considering these results, it would
appear that the catalytic behavior of LOx in CDHP is strongly
influenced by pH. These results also enable the effect of
the choline cation and the DHP anion to be discriminated
from that of pH. As LOx is tested at the same pH as the other
ILs (7.0  0.2), we can now assert that the specific ion effect of
the choline cation and the DHP anion on LOx is analogous to
the other ILs, since a similar reduction in the catalytic effi-
ciency of LOx compared to the IL-free solution, with respect to
other HyILs, is observed. Following these observations, the
previous anion series for LOx can be now amended to:
Cl > DHP > nitrate > Levulinate > Formate
Eﬀect of the ionic liquids on LOx lifetime
Enzyme lifetime/stability is critically important for the devel-
opment of a practically useful lactate biosensor.23 In order to
test this, the catalytic function of the enzyme in the various ILs
was tested and compared to similar experiments performed
under IL-free conditions and CCl. The experiments were per-
formed by periodical testing of LOx solutions stored at 5 1C and
37 1C, which correspond to standard storage temperature of
home chilling units and average body temperature, respec-
tively. Fig. 6 shows the variation in initial velocity v of LOx over
a period of 140 days. The y-axis reports the percentage ratio (i.e.,
v/v0  100), where v0 is the initial velocity of the enzyme
immediately (day 0) after dissolution in HyILs, CCl or IL-free
solutions (pre-incubated at 25 1C for 2 h).
The inset graphs of Fig. 6 shows the trend during the first 21
days at each temperature. In both cases, the fastest loss occurs
with HyCL, HyCN, HyCT and HyCF. The decrease is particularly
pronounced at 37 1C, with the enzyme activity in these ILs
collapsing to almost zero within a few days.
Over a longer time period, enzyme activity was best pre-
served in CCl, when stored at 5 1C, with over 90% of the original
day 0 activity retained for 100 days, dropping to ca. 80% after
140 days. It is worth noting that this is significantly better than
the results obtained in IL-free solution under the same condi-
tions, which were ca. 65% (day 100) and ca. 40% (day 140),
suggesting a pronounced stabilisation of the enzyme when in
the presence of CCl. Next to CCl, the best results at 5 1C were
obtained with HyCDHP, for which the performance was very
similar to IL-free solution. For the other ILs, the decrease in
Table 3 Kinetic parameters and pH values of LOx in IL-free solution and
in the presence of CDHP/B and CDHP at the final concentration of 0.5 M
KM [mM] kcat [s
1] kcat/KM [s
1 mM1] pH no LA
IL-free 0.370 78.80 210.81 7.0
CDHP/B 0.452 59.05 130.64 6.8
CDHP 0.872 38.26 43.88 6.0
Fig. 5 Initial velocity of LOx versus substrate concentration for IL-free
solution, CDHP and CDHP/B (n = 3). IL-free solution and CDHP curves are
reported from Fig. 4 just for comparison. IL concentration in the final assay
is equal to 0.5 M. Fitting curves results of exponential Michaelis–Menten
non-linear fitting.
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stability was much more marked, the best being HyCDHP/B, in
which the LOx was still reasonably active (ca. 85%) after 30 days.
At 37 1C, the decrease in enzyme stability was more pro-
nounced, as would be expected because the energetic barrier
for the enzymatic deactivation is lower compared to 5 1C. The
best performing solution was again CCl, with results very
similar to those obtained under IL-free conditions, with both
retaining ca. 80% of the day 0 activity for 20 days (inset). Next
best was HyCDHP (ca. 50% day 0 activity after 20 days). Over a
longer period, the trend was similar, with CCl E IL-free
solution (both retaining ca. 25% day 0 activity), followed by
CDHP (eﬀectively reaching zero after ca. 120 days).
These results confirmed the beneficial eﬀect of CCl for LOx,
especially when it is stored at 5 1C with less than 25% loss in
activity after the period of test. This result confirms the
stabilising eﬀect of CCl observed in the residual activity study
(Fig. 3). HyCDHP is also confirmed as the best stabilising of the
tested HyILs, although it does not give any better conditions
compared to the IL-free solution. For the latter, LOx showed an
unexpectedly extended lifetime and further investigation will be
necessary to elucidate the cause.
With regard to CCl and HyCDHP, it is worth mentioning
here that the chosen storage conditions of the enzyme in these
two systems were not identical, since CCl was a 1 molar
solution of the salt in PBS while CDHP was used as a hydrated
salt with a final water content of 25% w/w. In light of these
diﬀerences, the resulting long-term stability of LOx would be
influenced by the diﬀerent salt contents. Therefore, the data in
Fig. 6 should be interpreted as two sets of results in which the
presence of CCl in aqueous solution provides LOx more favor-
able and stabilising conditions compared to conventional PBS
(IL-free). On the other hand, the use of HyCDHP as unconven-
tional solvent for the enzyme did not lead to a better lifetime
stability when compared to the IL-free solution, although it
provides the most suitable stabilising environment with regard
to all the other tested HyILs.
It is also worth noting that, although HyCT cannot be
considered to stabilise LOx as well as HyCDHP, at 5 1C an
improved stabilisation eﬀect on LOx was observed compared to
the HyILs of CL, CN and CF. These results suggested that the
specific ion eﬀect of ILs on proteins can be, in general, quite
diﬀerent when in HyILs or in solution at high concentration of
ILs, e.g. 0.5 M concentration.
For instance, it was not possible to obtain any kinetic
parameters in the presence of CT, due to the low pH given by
the tartrate anion in solution, as explained before; however, in
HyCT lactate oxidase retained about 10% of its initial activity
after 140 days, as shown in Fig. 6 at 5 1C. The origin of this
result is not particularly clear but it might be attributed to the
diﬀerent water activity (aw) of the two systems, which can
influence the overall eﬀective-pH of solution. In fact with the
variation of aw the dissociation equilibrium of the tartrate
anion can shift, with the final result being significant diﬀerences
in the enzyme environment where it is dissolved. In this regard,
in addition to the specific ion eﬀects of CT, aw/eﬀective-pH can
play a crucial role in the preservation of the biofunctionality of
the enzyme. Very recent findings from Thompson et al.44 showed
for HyCDHP the influence of aw on the eﬀective-pH in solution,
which here was proven to be an important parameter for the
retention of the enzyme biofunctionality.
Finally, the stability of LOx when stored in HyCDHP/B (52%
w/w ionic liquid) was also investigated. At 37 1C the loss of
activity has a similar trend to the one obtained with HyCN,
HyCF and HyCL, reaching zero just after 14 days. Nevertheless,
at 5 1C, the LOx deactivation during the first 20 days was found
to be less pronounced, perhaps indicating the beneficial eﬀect
of the choline DHP. Thereafter, a faster loss occurred, retaining
only 10% of its initial velocity after 140 days.
Conclusions
This work reports the influence of several biocompatible choline
HyILs on the native structure and bioactivity of lacate oxidase, an
important enzyme for the realisation of lactate biosensors. The
study of the secondary structure of the enzyme showed diﬀerences
in the a-helix and b-sheet content in HyCDHP; with a marked
Fig. 6 Long term stability of LOx when stored at 5 1C (top) and 37 1C
(bottom) in the HyILs, IL-free and CCl solutions. The normalised enzyme
initial velocity on the y-axis represents the ratio of the initial velocity v of
the tested sample to the initial velocity v0 of the freshly made LOx stock
solutions. Inset graphs show the collected data points during the first
21 days of the study (n = 3).
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decrease of a-helices and increase of b-sheets. However, this does
not seem to aﬀect the enzyme activity, which overall is more stable
when thermal denaturation is induced. Moreover, irreversible
enzyme deactivation is diminished when using HyCDHP and CCl
solutions.
The kinetic parameters also revealed a significant IL eﬀect
on the catalytic eﬃciency, which is strongly influenced by the
nature of the anion. Interestingly, the acid character of the DHP
anion had a negative influence on the biocatalysis of lactic acid,
most likely due to the associated increased acidity, a critical
parameter for optimising enzyme stability and performance.
However, by using an IL ‘‘buﬀer’’, such as CDHP/B, it was
possible to study the real ion eﬀects of the choline cation and
the DHP anion on the enzyme performance, as this allowed
precise control of the pH of the solution.
In addition, long-term stability studies showed a remarkable
specific ion eﬀect on the enzyme, especially for choline chloride,
for which ca. 80% of the initial (day 0) activity is retained after
140 days when stored at 5 1C. Finally, HyCDHP performs as well
as IL-free (PBS buﬀer) solutions in terms of LOx stabilisation. In
this regard, future studies will focus on the establishment of a
better correlation between the water content in HyILs and the
protein lifetime.
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